Integrated Biopharma INC Form 4 insider transactions

OQX
Director Damon DeSantis reports acquisition of stock options in Integrated BioPharma Inc.
OQX
Director Eric J Friedman acquired 50,000 stock options in Integrated BioPharma Inc. on August 7, 2024.
OQX
Director William Milmoe acquired 50,000 stock options in Integrated BioPharma Inc. on August 7, 2024.
OQX
Robert Canarick, a director of Integrated BioPharma, Inc., acquired 50,000 stock options on August 7, 2024, exercisable at $0.18.